In two experimental models of IBD, genetic ablation of ST2 significantly improved signs of colitis, while a sustained epithelial expression of the cyto-protective factor connexin-43 was observed in DSS-treated ST2-deficient mice. Here, IL1RL1 is linked to inflammatory bowel disease.